Tag: WSC 2026
Post-hoc imaging analysis of CHARM trial identifies “promising” treatment signals in...
Brainomix and Remedy Pharmaceuticals have announced “promising new findings” from a post-hoc analysis of the Phase 3 CHARM trial. Presented at last week’s World...
World Stroke Congress: Researchers share new insights on tailoring BP management...
Late-breaking research presented at the 2026 World Stroke Congress (WSC; 21–23 October, Seoul, South Korea) has provided fresh insights on the benefits of individualised...
Resolve presents preclinical data on NET degradation and nuclease therapy in...
Resolve Therapeutics has announced two e-posters featuring preclinical data on its RNase-Fc fusion protein RSLV-132, and its bispecific RNase/DNase-Fc fusion protein RSLV-145, shared at...
